Thymalin lineage: thymus-derived preparation — US5070076A
Vyacheslav G. Morozov, Vladimir K. Khavinson · 1991 · US5070076A · patent family 27262725
Published 1991-12-03.
Reported patent results
Reported findings
The patent reports recovery and basic characteristics of the thymus-derived powder.
Thymus-preparation process examples and analytical description; extract manufacture rather than a defined-peptide clinical trial.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Example product recovery | 5.6 g of dry material reported from 500 g of starting thymus tissue | Manufacturing result; no clinical response denominator |
| Product characteristics | Polypeptide molecular-weight range 600–6,000 Da; pH of a 1% solution reported as 5.4 | An extract characterization, not proof of a single active sequence |
Manufacturing recovery and physical properties cannot establish efficacy or equivalence of every current Thymalin product. No new controlled clinical result is supplied by these process examples.
Source for the extracted data ↗ · Checked 2026-11-06
Patent claims and provenance
Manufacturing. The patent describes preparation of a biologically active material from thymus glands.
This is an extract-process source, not proof that the extract is identical to a purified EW or EDP peptide or that all current products are equivalent.
- Publication
- US5070076A ↗ · 1991-12-03
- Earliest priority / filing
- 1985-07-02 / 1989-11-15
- Original applicant / assignee
- Leningradsky Gosudarstvenny Pedagogichesky Institut
- Indexed status
- Expired - Fee Related · checked 2026-11-06
- Patent family
- 27262725 · family publications are related filings, not independent studies.
Original title, inventors and related publications
Thymus-gland preparation and method for producing same
Inventors: Vyacheslav G. Morozov; Vladimir K. Khavinson.
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- This is an extract-process source, not proof that the extract is identical to a purified EW or EDP peptide or that all current products are equivalent.
- Manufacturing recovery and physical properties cannot establish efficacy or equivalence of every current Thymalin product. No new controlled clinical result is supplied by these process examples.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; the record gives its source-check date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original patent text and indexed metadata
Review depth: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related-report group: patent-family-27262725. Reports in this group are not assumed to be independent trials.
Source access and review scope
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.
Source type: Patent publication
Citation and original source
Original source: Vyacheslav G. Morozov, Vladimir K. Khavinson. Thymalin lineage: thymus-derived preparation — US5070076A US5070076A · patent family 27262725 1991.
Molekul research summary: https://molekul.io/research/patent-us5070076a. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry